Accelerating Clinical Research with a Suite of Comprehensive Services

Our in-house medical, regulatory and operational experts work collaboratively to support your Phase IIb-III clinical trials. We combine scientific leadership with disciplined execution, global access to patients, and local and global regulatory expertise to accelerate your compound to approval.

Key Differentiators

  • Full-time physicians provide strategic direction for study design and planning, train operations staff, work with primary investigators, provide medical monitoring, and meet with regulatory agencies
  • Strategic regulatory leadership guides trial design and execution recommendations
  • Long-standing interactions at the medical and operational levels with global key academic opinion leaders and key sites including preferred CRO status at specific sites
  • Close collaborations and ongoing programs with high recruiting sites at academic, network, and independent centers
  • Dedicated global regulatory submissions teams experienced in key therapeutic area and specialty area trial application processes and site start-up
  • In-house contract attorneys to expedite contract negotiations and final execution
  • Proprietary, integrated clinical study management technology platform facilitates efficient execution of global trials
  • Experienced in Data Safety Monitoring Committee management as well as providing ongoing statistical support
  • Detailed country and site selection processes to use the best site mix for the program as well as ongoing tracking and site communication to maintain trial timelines
  • Focused teams permit Medpace to address each program’s specific needs and to provide consistent operational excellence
  • Comprehensive and rigorous internal training for CRAs